Indication
Chronic Hepatitis
2 clinical trials
6 products
Product
AB-836Clinical trial
A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AB-836, an HBV Capsid Inhibitor, in Healthy Subjects and Subjects With Chronic HBV InfectionStatus: Terminated, Estimated PCD: 2022-11-17
Product
Nucleos(t)ide AnalogueProduct
PlaceboClinical trial
Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) InfectionStatus: Active (not recruiting), Estimated PCD: 2020-03-04
Product
HCV DNA Vaccine INO-8000Product
Rocakinogene